Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AD2000: donepezil in Alzheimer's disease.

× No keyword cloud information.

19 in total

Review 1. Long-term cholinesterase inhibitor treatment of Alzheimer's disease.

Authors: Peter Johannsen
Journal: CNS Drugs Date: 2004 Impact factor: 5.749

2. Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease.

Authors: H Fillit; J Cummings; P Neumann; T McLaughlin; P Salavtore; C Leibman
Journal: J Nutr Health Aging Date: 2010-10 Impact factor: 4.075

3. Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease.

Authors: H Peter Schmitt
Journal: Psychopharmacology (Berl) Date: 2004-12-24 Impact factor: 4.530

Review 4. [Present status and future possibilities of adjuvant pharmacotherapy for aphasia].

Authors: C Korsukewitz; C Breitenstein; M Schomacher; S Knecht
Journal: Nervenarzt Date: 2006-04 Impact factor: 1.214

5. [Cognition on demand?--The wish for cognition-enhancing drugs in medicine].

Authors: Matthis Synofzik
Journal: Ethik Med Date: 2006-03 Impact factor: 0.474

6. An innovative approach to involve patients in measuring treatment effects in drug trials.

Authors: Hanna Kaduszkiewicz
Journal: CMAJ Date: 2006-03-22 Impact factor: 8.262

7. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity?

Authors: Kenneth M Langa; Eric B Larson; Jason H Karlawish; David M Cutler; Mohammed U Kabeto; Scott Y Kim; Allison B Rosen
Journal: Alzheimers Dement Date: 2008-03-04 Impact factor: 21.566

8. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.

Authors: Eun Kyung Lee; Yu Jeung Lee
Journal: Int J Clin Pharm Date: 2013-05-25

9. Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.

Authors: Joshua D Vardigan; Christopher E Cannon; Vanita Puri; Mandy Dancho; AmyJo Koser; Marion Wittmann; Scott D Kuduk; John J Renger; Jason M Uslaner
Journal: Psychopharmacology (Berl) Date: 2014-12-10 Impact factor: 4.530

Review 10. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors: Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal: Int J Mol Sci Date: 2009-06-03 Impact factor: 6.208